Mentalizing Skills Deficits in Schizophrenia as a Clue for Drug Choice: Clozapine Versus Other Antipsychotics on Keeping Outpatients Stable

QR Code

Mentalizing Skills Deficits in Schizophrenia as a Clue for Drug Choice: Clozapine Versus Other Antipsychotics on Keeping Outpatients Stable

None

Saved in:

Bibliographic Details
Main Authors:	Duñó, Rosó, Langohr, Klaus, Palao, Diego, Tobeña, Adolf
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/25517
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Use of third-generation antipsychotics in combination with clozapine in the treatment of resistant schizophrenia
by: A. R. Asadullin, et al.
Published: (2025-06-01)

Following the Action of Atypical Antipsychotic Clozapine and Possible Prediction of Treatment Response in Schizophrenia
by: Mihai-Gabriel Năstase, et al.
Published: (2025-05-01)

Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-05-01)

Pattern of Antipsychotics in Schizophrenia Outpatients at Lampung Province Mental Hospital
by: Isnenia Isnenia
Published: (2022-03-01)

Monitoring of clozapine and norclozapine concentrations in schizophrenia treatment
by: N. V. Baymeeva, et al.
Published: (2018-02-01)

The antipsychotics functional index (AFI) in schizophrenia
by: Gabriel-Cristian Marinescu, et al.
Published: (2025-07-01)

Clozapine-Induced Rhabdomyolysis in a Patient With Paranoid Schizophrenia: A Case Study Highlighting the Importance of Vigilance in Antipsychotic Therapy and Recurrence During Re-Challenge
by: Nitish Jayanth Kumaraswamy, et al.
Published: (2025-06-01)

Augmentation of Clozapine in Treatment Resistant Schizophrenia – Is There a Superior Strategy?
by: Priya Babla, et al.
Published: (2025-06-01)

Repurposed Antipsychotics as Potential Anticancer Agents: Clozapine Efficacy and Dopaminergic Pathways in Neuroblastoma and Glioblastoma
by: Catarina Moura, et al.
Published: (2025-07-01)

Correction: The antipsychotics functional index (AFI) in schizophrenia
by: Gabriel-Cristian Marinescu, et al.
Published: (2025-07-01)

APPLICATION OF ANTIPSYCHOTICS OF LONG-TERM ACTION IN SCHIZOPHRENIA
by: Zh. B. Bibekova, et al.
Published: (2020-03-01)

Case Study – Restarting Clozapine in a Patient With Treatment Resistant Schizophrenia
by: Sabaritha Subramania Pillai, et al.
Published: (2025-06-01)

Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-08-01)

Peculiarities of personalized selection of antipsychotic drugs for schizophrenia treatment
by: O.O. Khaustova, et al.
Published: (2024-04-01)

Clozapine Rechallenge in Treatment-Resistant Schizophrenia: Clinical and Ethical Considerations After Ileus
by: Lily Farakish, et al.
Published: (2025-06-01)

Electrophysiological Deficits in Schizophrenia: Models and Mechanisms
by: Jutzeler, Catherine R., et al.
Published: (2011)

Combined use of antipsychotics and electroconvulsive therapy in theurapetically resistant schizophrenia
by: S. V. Sizov, et al.
Published: (2018-07-01)

Replacement of antipsychotics as a method of preventing the formation of resistance in schizophrenia
by: G. E. Mazo, et al.
Published: (2018-07-01)

Candidate genes of the development of antipsychotic-induced parkinsonism in patients with schizophrenia
by: E. E. Vaiman, et al.
Published: (2021-12-01)

Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia
by: Cheng M, et al.
Published: (2016-03-01)

Comparative analysis of EEG in patients with schizophrenia receiving various atypical antipsychotics
by: S. A. Galkin, et al.
Published: (2024-04-01)

Sexual differences in the clinical features of antipsychotic-induced hyperprolactinemia in patients with schizophrenia
by: E. G. Kornetova, et al.
Published: (2019-10-01)

Imaging transcriptional pattern of the substantia Nigra predicts response to antipsychotics in schizophrenia
by: Long-Biao Cui, et al.
Published: (2025-06-01)

Shots in Practice: An Audit of Depot Antipsychotics in Pakistan’s Outpatient Psychiatry Department
by: Asma Suleman, et al.
Published: (2025-06-01)

Physical Health Monitoring of Patients Prescribed Depot Antipsychotic Medication and Clozapine in the North-West Edinburgh Community Mental Health Team
by: Andrew Revadillo, et al.
Published: (2025-06-01)

Morphophenotypic predictor of the development of visceral obesity in patients with schizophrenia receiving antipsychotic therapy
by: E. G. Kornetova, et al.
Published: (2018-12-01)

Candidate genes involved in the development of antipsychotic-induced tardive dyskinesia in patients with schizophrenia
by: E. E. Vaiman, et al.
Published: (2020-12-01)

Choice of Treatment Used in a Patient With Antipsychotic-Induced Rhabdomyolysis
by: Mizanoor Rahman, et al.
Published: (2025-06-01)

Clues to winning play:
by: Roth, , D, L. M.
Published: (1987)

Follow-up Care among Medicaid Patients with Schizophrenia treated with Antipsychotics in the Inpatient Setting
by: Amanda M. Farr, et al.
Published: (2014-10-01)

The effect of antipsychotic-induced extrapyramidal disorders on patient’s compliance with schizophrenia (a clinical case)
by: E. G. Rahim, et al.
Published: (2022-01-01)

CLINICAL AND SOCIAL RISK FACTORS OF TARDIVE DYSKINESIA IN PATIENTS WITH SCHIZOPHRENIA DURING ANTIPSYCHOTIC TREATMENT
by: Ye. G. Kornetova, et al.
Published: (2015-02-01)

Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
by: Montemagni C, et al.
Published: (2016-04-01)

New Findings for Face Processing Deficits in the Mental Disorder of Schizophrenia
by: Onitsuka, Toshiaki, et al.
Published: (2011)

Clues to meaning: strategies for better reading comprehension /
by: Levine, Adina
Published: (1988)

Clozapine Prescribing in the General Hospitals
by: Hanna Tee, et al.
Published: (2025-06-01)

Guideline for the use of therapeutic drug monitoring of antipsychotics to individualize the selection of therapy in the treatment of exacerbation of schizophrenia
by: S. S. Potanin, et al.
Published: (2023-12-01)

Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review
by: Karson C, et al.
Published: (2016-01-01)

Neurocognitive deficits in clinical polymorphism of schizophrenia: typology, expression and syndromal overlaps
by: A. N. Kornetov, et al.
Published: (2019-08-01)

Influence of clinical and therapeutic indicators on the severity of neurocognitive deficits in patients with schizophrenia
by: E. G. Kornetova, et al.
Published: (2020-10-01)